| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_8805543ef3a4e8ec2ba2d6751579a8ed |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K35-644
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P43-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K35-64
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K36-07
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P35-00 |
| filingDate |
2002-06-14-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_b9f7b9563ab34d247ee4fb589a03fa06
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_7996a9ae39b0310fdf177c13e3b9050d |
| publicationDate |
2004-01-22-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
JP-2004018437-A |
| titleOfInvention |
Anti-tumor composition, orally ingested composition, and method of suppressing animal tumor |
| abstract |
The present invention provides a novel antitumor composition exhibiting synergistic antitumor activity. The present invention provides an antitumor composition comprising an agaricus extract and a propolis extract. This composition exhibits higher antitumor activity than expected from the tumor volume inhibition rate in the case of Agaricus extract alone and the tumor volume inhibition rate in the case of propolis extract alone. [Selection] Figure 1 |
| isCitedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-104547442-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/JP-2018188412-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/JP-7054994-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/JP-2018177690-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/JP-2018193462-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/JP-2017508450-A |
| priorityDate |
2002-06-14-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |